3D Printed Muscle Tissues for Drug Discovery With Mantarray™ Platform by Curi Bio

by Natalia Honchar  (contributor )   •     

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   Biopharma insight    # Biotech   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue contractility analysis. Curi’s Mantarray platform can serve for the discovery of new therapeutics by providing parallel analysis of 3D EMTs with adult human-like functional profiles of healthy and disease models.

3D bioprinting

Image credit: luplupme iStock

 

It goes without saying that when the drug is developed, it needs to be tested on a highly relevant model before being approved for the clinical trials. Do we have such highly relevant models for all diseases? Obviously, no. But there are some advances which bring us closer to literally “crafting” such models by ourselves -- 3D tissue printing. 

Continue reading

This content available exclusively for BPT Mebmers

Topics: Biotech   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email